Investigating Outcomes Following the Use of Selective Serotonin Reuptake Inhibitors for Treating Depression in Pregnancy: A Focus on Methodological Issues

Author： Grzeskowiak Luke E.  

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.34, Iss.11, 2011-11, pp. : 1027-1048

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Selective Serotonin Reuptake Inhibitors in Pregnancy

By  

Current Medicinal Chemistry, Vol. 19, Iss. 27, 2012-09 ,pp. : 4554-4561

Bentham Science Publishers

Access to resources Recommend Favorite

Safety of Selective Serotonin Reuptake Inhibitors in Pregnancy

By Alwan Sura   Friedman Jan M.  

CNS Drugs, Vol. 23, Iss. 6, 2009-05 ,pp. : 493-509

Adis International

Access to resources Recommend Favorite

Use of Selective Serotonin Reuptake Inhibitors in Children and Adolescents

By Ian C.K. Wong  

Drug Safety, Vol. 27, Iss. 13, 2004-01 ,pp. : 991-1000

Adis International

Access to resources Recommend Favorite

Use of selective serotonin reuptake inhibitors during pregnancy and breastfeeding has both benefits and risks

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 22, Iss. 3, 2006-03 ,pp. : 22-26

Adis International

Access to resources Recommend Favorite

Medical Resource Use and Cost of Venlafaxine or Tricyclic Antidepressant Therapy: Following Selective Serotonin Reuptake Inhibitor Therapy for Depression

By Griffiths R.I.  

PharmacoEconomics, Vol. 15, Iss. 5, 1999-05 ,pp. : 495-505

Adis International

Access to resources Recommend Favorite